Solara Active Pharma temporarily suspends production of Ranitidine Hydrochloride drug

27 Sep 2019 Evaluate

Solara Active Pharma Sciences has temporarily suspended production and distribution of Ranitidine Hydrochloride drug substance. The Company has received request for information from USFDA and EDQM to provide test data on N-nitrosodimethylamine (NDMA) content in Ranitidine Hydrochloride drug substance. The Company is in the process of responding to the information request comprehensively by second week of October 2019.

Solara Active Pharma Sciences is a young, dynamic, entrepreneurial and customer oriented API manufacturer.

Solara Active Pharma Share Price

686.95 -33.60 (-4.66%)
20-Dec-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1808.50
Dr. Reddys Lab 1342.45
Cipla 1472.45
Lupin 2147.55
Zydus Lifesciences 973.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.